VITRAC Therapeutics, LLC

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2022-05-16
Last Posted Date
2023-09-28
Lead Sponsor
Vitrac Therapeutics, LLC
Target Recruit Count
4
Registration Number
NCT05374538
Locations
🇺🇸

New York University Langone Health Perlmutter Cancer Cancer, New York, New York, United States

🇺🇸

University of California Davis, Sacramento, California, United States

🇺🇸

Emory University Winship Cancer Center, Atlanta, Georgia, United States

and more 2 locations
© Copyright 2024. All Rights Reserved by MedPath